Time Passages

U.S. canna awaits it's turn.

Daily Recap

Marijuana remains in an odd legal limbo in the U.S., and there's one organization at the center of it all: the Drug Enforcement Administration.

The DEA has for decades held that marijuana is among the most dangerous, highly addictive drugs that has no medical value despite growing state laws, 252-pages of fresh medical evidence and mounting popular opinion to the contrary.

Hoos Zooming Hoo?

A Virginia House panel has delayed its consideration of a Senate-passed marijuana legalization bill to allow backers of two competing legal sales proposals—both of which were approved by floor votes in their respective chamber—more time to find compromise that’ll allow this legislation to move forward.

New Hampshire

New Hampshire could join its New England peers and become the 25th state in the nation to legalize adult-use cannabis with House lawmakers set to take up legislation Feb. 22 on the chamber’s floor.

They’ll look to move legislation that can gain traction in a historically resistant Senate and please a governor who’s already pledged support for an adult-use program as long as certain conditions are met.

Stocks & Stuff

It was another quiet session in Cannaland as volumes continued to pace well below recent trends. U.S. Cannabis ETF MSOS finished near the flatline in what can best be described as underwhelming action.

Below, we preview U.S. canna earnings, channel check canna credit, look at leaderships’ levels of lore, share random thoughts and spy some SAFE news.

All that and more, just scroll down.

note: tomorrow will be a travel day.

SPY 0.00%↑ QQQ 0.00%↑ IWM 0.00%↑ MSOS 0.00%↑ PT Notional: $67M ($31M)

Top Stories